REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

09/01/2019 09:50

RNS Number : 6276M
Morgan Stanley
09 January 2019
 


 
 FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken
     For an opening position disclosure, state the latest practicable date prior to the disclosure


08 JANUARY 2019




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
     If it is a cash offer or possible cash offer, state "N/A"


Yes - Shire plc
 



 
 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
 (a)       Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



 Class of relevant security:


Ordinary
 








 Interests


Short positions
 




 Number


  %


Number


  %




 (1) Relevant securities owned  and/or controlled:


4,423,915


0.56


35,544,949


4.53




 (2) Cash-settled derivatives:


34,686,223


4.42


3,545,959


0.45
 




 (3) Stock-settled derivatives (including options) and  agreements to purchase/sell:


315,000


0.04


315,000


0.04




  TOTAL:


39,425,138


5.03


39,405,908


5.02
 



 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



 Class of relevant security in relation to which subscription right exists:


 N/A




 Details, including nature of the rights concerned and relevant percentages:


 N/A



 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
 
(a)        Purchases and sales
 



 Class of
relevant
security


 Purchases/
sales


 Total number
of securities


 Highest price
per unit paid/received


 Lowest price
per unit paid/received




 Ordinary


 PURCHASES


 3,061,136


 4,150.3600 JPY


 3,972.2495 JPY
 




 Ordinary


 SALES


 3,014,772


 4,150.3600 JPY


 3,972.2495 JPY
 



 
(b)        Cash-settled derivative transactions
 



  Class of
relevant
security


 Product description
 e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per
unit




Ordinary


CFD


SHORT


14500


4085.0000 JPY




Ordinary


CFD


LONG


27000


4064.2296 JPY




Ordinary


CFD


SHORT


68300


4096.2152 JPY




Ordinary


CFD


LONG


7000


4085.0000 JPY




Ordinary


CFD


SHORT


24900


3977.1927 JPY




Ordinary


CFD


LONG


32700


4067.0366 JPY




Ordinary


CFD


SHORT


6500


4046.0000 JPY




Ordinary


CFD


LONG


39200


4061.2015 JPY




Ordinary


CFD


SHORT


1800


4068.1666 JPY




Ordinary


CFD


SHORT


5400


4082.4074 JPY




Ordinary


CFD


LONG


3800


4068.4210 JPY




Ordinary


CFD


LONG


200


4043.0000 JPY




Ordinary


CFD


LONG


300


4068.1086 JPY




Ordinary


CFD


LONG


4300


4068.1086 JPY




Ordinary


CFD


SHORT


300


4056.0000 JPY




Ordinary


CFD


SHORT


9100


4057.8461 JPY




Ordinary


CFD


LONG


8400


4061.5357 JPY




Ordinary


CFD


SHORT


2400


4037.9166 JPY




Ordinary


CFD


LONG


1200


3995.0000 JPY




Ordinary


CFD


LONG


111196


4056.1075 JPY




Ordinary


CFD


SHORT


155697


4010.1029 JPY




Ordinary


CFD


LONG


65800


4064.7501 JPY




Ordinary


CFD


LONG


601408


4043.0780 JPY




Ordinary


CFD


SHORT


703308


4062.0253 JPY



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



 Class
of
relevant
security


 Product description  e.g. call option


 Writing, purchasing,
selling,
varying etc.


 Number
of securities to which option relates


 Exercise price
per unit


 Type
e.g. American, European etc.


 Expiry date


 Option money paid/ received per unit
 




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A  
 



 
(ii)        Exercise
 



 Class of
relevant
security


 Product description
e.g. call option


 Exercising/
exercised
against


 Number of securities


 Exercise price
per unit
 




 N/A


 N/A


 N/A


 N/A


 N/A  
 



 
(d)        Other dealings (including subscribing for new securities)
 



 Class of relevant
security


 Nature of dealing
e.g. subscription, conversion


 Details


 Price per unit (if applicable)




 N/A


 N/A


 N/A


 N/A  
 



 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
NONE
 



 
 
 (b)       Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between
the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
NONE
 



 
(c)        Attachments
 



   Is a Supplemental Form 8 (Open Positions) attached?


                 YES  
 



 
 



 Date of disclosure:


 09 JANUARY 2019
 




 Contact name:


 Craig Horsley
 




 Telephone number:


 +44(141) 245 7736
 



 
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 
 
 
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 



Full name of person making disclosure:


Morgan Stanley MUFG Securities Co., Ltd.




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical Company Limited



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 



Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities
to which
option or
derivative relates


Exercise
price
per unit


Type
e.g. American,
European
etc


Expiry
date




Ordinary


PUT


PURCHASED


125,000


4507.0000 JPY


European


13/12/2019




Ordinary


CALL


PURCHASED


125,000


4507.0000 JPY


European


13/12/2019




Ordinary


PUT


PURCHASED


60,000


4596.0000 JPY


European


14/06/2019




Ordinary


CALL


PURCHASED


60,000


4596.0000 JPY


European


14/06/2019




Ordinary


PUT


PURCHASED


65,000


4414.0000 JPY


European


14/06/2019




Ordinary


CALL


PURCHASED


65,000


4414.0000 JPY


European


14/06/2019




Ordinary


PUT


PURCHASED


65,000


4414.0000 JPY


European


13/12/2019




Ordinary


CALL


PURCHASED


65,000


4414.0000 JPY


European


13/12/2019



 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEANFNELPNEEF